Stanford & NVIDIA's Evo 2, AI-Driven Drug Discovery, and ModMed Acquisition - Life AI Weekly #7

Hi there,

Welcome to this week's edition of Life AI Weekly, where we delve into the latest advancements in Healthcare and Life Sciences AI. This week, we highlight several significant developments in the field. Volpara Health has appointed a new CEO and is integrating with BOADICEA to enhance their healthcare offerings. Meanwhile, HealthTree Foundation has introduced an AI Clinical Trial Finder, aiming to streamline the process of matching patients with suitable clinical trials.

In other news, NewVue.ai and RamSoft have partnered to provide AI solutions in radiology, and Juno Health is collaborating with Avo to incorporate an AI scribe into their Electronic Health Records (EHR) system. Additionally, Baird Medical presented its microwave ablation technology at NASOIE 2025, showcasing innovative approaches in medical treatment. Stay tuned as we explore these stories and more in this edition.

ModMed, a healthcare SaaS platform, has received a majority growth investment from Clearlake Capital, acquiring the company from Warburg Pincus. Ignota Labs, a UK-based biotech startup, has raised $6.9 million in seed funding to advance its AI platform SAFEPATH, which addresses drug toxicity issues in clinical trials. The Munich-based digital medtech startup Hema.to has secured €3.6 million in funding to advance its AI technology for blood cancer diagnosis.

IDEAYA Biosciences has partnered with ATTMOS to enhance drug discovery for oncology using AI and machine learning. AION Labs, in partnership with BioMed X, has announced a global call for applications to find scientific founders for a new startup focused on using generative AI for drug discovery.

Stanford University, the Arc Institute, and NVIDIA have developed Evo 2, an AI model for predicting genetic variations and generating genomic sequences. Trained on 9.3 trillion DNA base pairs, it can predict mutation effects and engineer DNA sequences.

Volpara Health has announced that Craig Hadfield will become the new CEO, succeeding Teri Thomas in April 2025. The company has also integrated its breast density assessment into the BOADICEA model, and presented 21 research abstracts at ECR 2025. The HealthTree Foundation has launched an AI-powered tool to help Multiple Myeloma patients find suitable clinical trials by analyzing their medical records. NewVue.ai and RamSoft have announced a strategic partnership to integrate NewVue.ai's EmpowerSuite into RamSoft's PowerServer and OmegaAI platforms, aiming to enhance radiology workflow orchestration.